Format

Send to

Choose Destination
J Hepatol. 2016 Apr;64(1 Suppl):S41-S48. doi: 10.1016/j.jhep.2016.02.009.

Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.

Author information

1
Cancer Research Center of Lyon (CRCL), Lyon 69008, France; INSERM U1052, CNRS UMR-5286, Lyon 69008, France; University of Lyon, Université Claude-Bernard (UCBL), 69008 Lyon, France.
2
Institute of Virology, Technische Universität München/Helmholtz Zentrum München, Trogerstrasse 30, 81675 Munich, Germany; German Center for Infection Research (DZIF), Munich Site, Germany. Electronic address: protzer@tum.de.

Abstract

HBV deposits a covalently closed circular DNA form, called cccDNA, in the nucleus of infected cells. As the central transcription template, the cccDNA minichromosome is a key intermediate in the HBV life cycle. Its location in the nucleus makes cccDNA a difficult target for antivirals and immune response, and therefore it is responsible for chronicity of HBV infection. While little is known about the mechanisms involved in cccDNA formation, current research is accumulating data on the mechanisms regulating transcription from cccDNA, and the first potential targeting approaches have been reported. This review will summarize our knowledge about cccDNA biology and the latest advances in cccDNA targeting strategies in order to finally achieve an HBV cure.

KEYWORDS:

Hepatitis B virus; Liver; cccDNA

PMID:
27084036
DOI:
10.1016/j.jhep.2016.02.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center